CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Net Current Assets History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Current Assets (Including Current Investments) | ₹14,147 Cr | ₹11,772 Cr | ₹9,798 Cr | ₹8,590 Cr | ₹7,311 Cr |
What is the latest Net Current Assets ratio of CIPLA ?
Year | Net Current Assets |
---|---|
Mar2024 | ₹14,147 Cr |
Mar2023 | ₹11,772 Cr |
Mar2022 | ₹9,798 Cr |
Mar2021 | ₹8,590 Cr |
Mar2020 | ₹7,311 Cr |
How is Net Current Assets of CIPLA Trending?
Years | Net Current Assets | % Change | |
---|---|---|---|
Mar2024 | ₹14,147 Cr | 20.17 | |
Mar2023 | ₹11,772 Cr | 20.15 | |
Mar2022 | ₹9,798 Cr | 14.06 | |
Mar2021 | ₹8,590 Cr | 17.50 | |
Mar2020 | ₹7,311 Cr | - |
Compare Net Current Assets of peers of CIPLA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CIPLA | ₹118,164.0 Cr | 3.4% | 0.1% | -3.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹404,900.0 Cr | -1.3% | 4.7% | 3.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹148,474.0 Cr | 1.9% | 1.5% | 41.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹105,849.0 Cr | -4.8% | 1.9% | 20.3% | Stock Analytics | |
MANKIND PHARMA | ₹97,009.6 Cr | -4% | 4% | -1.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹92,553.6 Cr | -0.1% | -1% | -11.3% | Stock Analytics |
CIPLA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CIPLA | 3.4% |
0.1% |
-3.1% |
SENSEX | -1.5% |
1.1% |
1.2% |
You may also like the below Video Courses